| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | Jul 1, 2025 | Genprex, Inc. | Chief Medical Officer | Sell | 47.5 | -4,500 | -20.03% | ✗ | $1K |
| Feb 18, 2025 | Feb 19, 2025 | Genprex, Inc. | Chief Medical Officer | Sell | 47.5 | -585 | -2.54% | ✗ | $239.9 |
| Feb 18, 2024 | Feb 21, 2024 | Genprex, Inc. | Chief Medical Officer | Sell | 47.5 | -1,319 | -21.53% | ✗ | $5.8K |
| Mar 6, 2018 | Mar 19, 2018 | Actinium Pharmaceuticals, Inc. | Chief Medical Officer | Buy | 90.0 | +14,000 | 280.00% | ✗ | $7K |
| Jun 15, 2017 | Jun 15, 2017 | Actinium Pharmaceuticals, Inc. | Chief Medical Officer | Buy | 90.0 | +5,000 | 100.00% | ✗ | $5.6K |